Corbevax, Covovax, Anti-Viral Drug Molnupiravir Approved by Drug Regulator CDSCO
The announcement comes a day after the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) recommended granting emergency use authorisation (EUA) to the COVID-19 vaccines Covovax and Corbevax with certain conditions.
Central Drug Authority CDSCO has approved the Serum Institute of India's COVID-19 vaccine Covovax, Biological E's jab Corbevax and anti-Covid pill Molnupiravir for restricted use in emergency situation.
Drug regulator CDSCO approves vaccines Corbevax, Covovax, anti-viral drug Molnupiravir for restricted emergency use against COVID-19
— Press Trust of India (@PTI_News) December 28, 2021
Health Minister Dr Mansukh Mandaviya Congratulates India:
Congratulations India 🇮🇳
Further strengthening the fight against COVID-19, CDSCO, @MoHFW_INDIA has given 3 approvals in a single day for:
- CORBEVAX vaccine
- COVOVAX vaccine
- Anti-viral drug Molnupiravir
For restricted use in emergency situation. (1/5)
— Dr Mansukh Mandaviya (@mansukhmandviya) December 28, 2021
(The above story first appeared on LatestLY on Dec 28, 2021 11:20 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
